Navigation Links
Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
Date:10/2/2007

MURRYSVILLE, Pa., Oct. 2 /PRNewswire/ - Respironics, Inc. (Nasdaq: RESP) today announced that it has acquired 100% of the outstanding shares of Apollo Light Systems, Inc., a 20-year-old, privately held company and a leading manufacturer of light therapy systems for melatonin suppression and circadian rhythm sleep disorders. Operating under the name Apollo Health, the company is located in American Fork, Utah and has annual revenues of approximately $5 million. The base cash purchase price is $6.5 million, with provisions for additional payments to be made based on Apollo's operating performance over the next year. Total potential earn out payments are less than the base purchase price.

"Apollo's light therapy technologies further our strategy to expand into the broader sleep market. Apollo will become part of our Sleep Well Ventures business which is focused on pursuing opportunities in insomnia, circadian rhythm disorders and other sleep/wake market segments," stated John L. Miclot, President and CEO of Respironics. "Our intent is to broaden the scope of the company beyond our core business of obstructive sleep apnea and to enter white spaces where we can serve the needs of problems sleepers seeking medical devices that are easier and more natural to live with," Miclot added.

The company stated that the acquisition will not have a material impact on revenues or earnings and the company will not be changing its financial outlook or guidance based on this announcement.

Apollo Health is the leading provider of light therapy systems in the U.S. offering both tabletop and small handheld units. Apollo's products align with Respironics' existing professional sleep clinician and homecare provider channels and reach other channels including researchers in sleep and psychiatry, and practice-based physicians. Apollo's products are also sold through mass market retailers and direct internet sales.

Apollo's product line includes the briteLite(TM) Series Light Boxes, which use BRITEWAVE(TM) technology to create specific wavelengths that produce a circadian response while eliminating UV hazards, and the goLITE(R) Series Handheld Light Therapy Devices, which feature BLUEWAVE(R) technology, a narrow range of blue light found in natural sunlight.

Light therapy is a scientifically validated and effective treatment for sleep and circadian rhythm related disorders such as jet lag, chronic insufficient sleep and mood disorders. Light therapy treatment is currently available on a non-prescription basis and may be used across the broad spectrum of people suffering from sleep disorders to individuals who want to manage their body clock for optimal sleep quality and daytime performance.

Respironics is a leading developer, manufacturer and distributor of innovative products and programs that serve the global sleep and respiratory markets. Focusing on emerging market needs, the Company is committed to providing valued solutions to help improve outcomes for patients, clinicians and healthcare providers. Respironics markets its products in 141 countries and employs over 5,100 associates worldwide. Further information can be found on the Company's Web site: http://www.respironics.com.

FORWARD-LOOKING STATEMENT

This document contains forward-looking statements, including statements relating to, among other things, developments in the healthcare industry; the success of the Company's marketing, sales, and promotion programs; future sales, acceptance, and quality of the Company's products and programs; the results of clinical trials; the timing and success of new product introductions; new product development; anticipated cost savings; FDA and other regulatory requirements, enforcement actions, product recalls or related field actions; future results from acquisitions and strategic investments; growth rates in foreign markets; regulations and other factors affecting operations and sales outside the United States; foreign currency fluctuations; the effects of a major natural disaster, cyber-attack or other catastrophic event that results in the destruction or disruption of any critical business or information technology systems; customer consolidation and concentration; increasing price competition and other competitive factors in the manufacture, distribution, and sale of products; interest rate fluctuations; expiration of intellectual property rights; intellectual property and related litigation; other litigation; future levels of earnings and revenues; the number of equity awards granted to employees and changes in the Company's stock price; and third party reimbursement; all of which are subject to change. Actual results may differ materially from those described in any forward-looking statements. Additional information on potential factors that could affect the Company's financial results are included in the reports filed with the SEC, including the reports on Form 10-K, 10-Q and 8-K.

(C) 2007 Respironics, Inc. and its affiliates. All rights reserved.


'/>"/>
SOURCE Respironics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Fiserv acquires crime management software firm
2. GenTel acquires GlaxoSmithKline chip platform
3. Tushaus Computer acquires managed service business
4. RedPrairie acquires Denver software company
5. Eagle Technology acquires some synergy
6. Brady Corp. acquires Korean counterpart
7. Canadian firm acquires Silicon Logic
8. Imago acquires synergistic British firm
9. Fiserv acquires insurance, training product lines
10. Amazon acquires Madison-based Shopbop
11. Metavante acquires health-care payments firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ReportsnReports.com adds 2016 global ... on US, EU, China ... healthcare business intelligence collection of its growing online ... on the Flow Cytometry market spread across 153 ... tables and figures is now available at ...
(Date:4/26/2016)... ... 26, 2016 , ... BaseHealth , the comprehensive predictive ... as Chief Business Officer. Arianpour, a genomics pioneer and visionary commercial leader with ... recently Chief Commercial Officer of Pathway Genomics. He has held senior executive roles ...
(Date:4/26/2016)... ... 26, 2016 , ... Heidelberg Instruments, a leader in design, ... its Volume Pattern Generator (VPG) line of lithography systems. The breakthrough VPG+ system ... as a solution for mid volume direct write lithography applications. It utilizes ...
(Date:4/26/2016)... ... April 26, 2016 , ... This unique "Fertility Happy Hour" event will ... an opportunity to get the lowdown on female fertility and the reproductive technologies that ... Jesse Hade, of Boston IVF - The Arizona Center, will give a short presentation ...
Breaking Biology Technology:
(Date:3/10/2016)... 2016   Unisys Corporation (NYSE: UIS ) ... (CBP) is testing its biometric identity solution at the Otay ... to help identify certain non-U.S. citizens leaving the country. ... to help determine the efficiency and accuracy of using biometric ... will run until May 2016. --> the ...
(Date:3/3/2016)... March 3, 2016  FlexTech, a SEMI Strategic Association ... Innovation, Research & Development, Leadership in Education, and, in ... the 9 th year of the FLEXI Awards ... and individuals from past years . Judging was ... pre-described set of criteria, by a panel of non-affiliated, ...
(Date:3/1/2016)... March 1, 2016 ... addition of the  "Global Biometric Access ... to their offering. --> ... of the  "Global Biometric Access Control ... their offering. --> Research ...
Breaking Biology News(10 mins):